Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Edarbyclor indication?

See the DrugPatentWatch profile for Edarbyclor

What conditions is Edarbyclor approved to treat?

Edarbyclor (azilsartan medoxomil + chlorthalidone) is indicated for the treatment of essential (primary) hypertension in adults when blood pressure is not adequately controlled with azilsartan medoxomil or chlorthalidone alone [1].

When is Edarbyclor used versus each component by itself?

The combination is used when monotherapy with either azilsartan medoxomil or chlorthalidone does not bring blood pressure under adequate control [1].

Is Edarbyclor approved for anything besides hypertension?

No—its listed indication is for essential hypertension in adults, as a combination therapy for inadequate response to the individual components [1].

Source

  1. DrugPatentWatch.com | Edarbyclor (azilsartan medoxomil + chlorthalidone) indication information


Other Questions About Edarbyclor :

edarbyclor 40/25 edarbyclor 40/12.5 mg tablet price edarbyclor 40/25 price edarbyclor 40/12.5 edarbyclor drug profile: edarbyclor (azilsartan kamedoxomil; chlorthalidone) drug patents, fda exclusivity, litigation, drug prices drugpatentwatch originally published Alternatives to edarbyclor? Alternatives to edarbyclor?